Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Marijuana Abuse 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Surveys and Questionnaires 2 Saline Solution 2 Exercise 2 siltuximab 1 pegfilgrastim 1 oxycodone-acetaminophen 1 erenumab 1 Xylitol 1 Triamcinolone Acetonide 1 Triamcinolone 1 Transcranial Direct Current Stimulation 1 Touch 1 Telemedicine 1 Standard of Care 1 Remifentanil 1 Oxycodone 1 Myofascial Release Therapy 1 Morphine 1 Methods 1 Methadone 1 Mastectomy 1 Laughter Therapy 1 Kyphoplasty 1 Ketorolac Tromethamine 1 Ketorolac 1 Fluorouracil 1 Duloxetine Hydrochloride 1 Dronabinol 1 Curettage 1 Caregivers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pain × Dronabinol × Clear all

NCT06601218 2025-06-24

Impact of Daily Oral Cannabis Doses in Patients With Cancer

University of Kentucky

Phase 1 Recruiting

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡